BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16618111)

  • 1. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.
    Dixon AM; Stanley BJ; Matthews EE; Dawson JP; Engelman DM
    Biochemistry; 2006 Apr; 45(16):5228-34. PubMed ID: 16618111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for role of transmembrane helix-helix interactions in the assembly of the Class II major histocompatibility complex.
    King G; Dixon AM
    Mol Biosyst; 2010 Sep; 6(9):1650-61. PubMed ID: 20379596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain.
    Ashman JB; Miller J
    J Immunol; 1999 Sep; 163(5):2704-12. PubMed ID: 10453012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sea bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility complex: sequencing and structural analysis using 3D homology modelling.
    Silva DS; Reis MI; Nascimento DS; do Vale A; Pereira PJ; dos Santos NM
    Mol Immunol; 2007 Jul; 44(15):3758-76. PubMed ID: 17512596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
    Neumann J; Koch N
    J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC.
    Liang MN; Lee C; Xia Y; McConnell HM
    Biochemistry; 1996 Nov; 35(47):14734-42. PubMed ID: 8942634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
    Stumptner P; Benaroch P
    EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.
    Jasanoff A; Wagner G; Wiley DC
    EMBO J; 1998 Dec; 17(23):6812-8. PubMed ID: 9843486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine mutations within a transmembrane domain of Tar, an Escherichia coli aspartate receptor, can drive homodimer dissociation and heterodimer association in vivo.
    Sal-Man N; Shai Y
    Biochem J; 2005 Jan; 385(Pt 1):29-36. PubMed ID: 15330757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
    Powis SJ
    FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.
    Laufer TM; Smiley ST; Ranger A; Clements VK; Ostrand-Rosenberg S; Glimcher LH
    J Immunol; 1997 Dec; 159(12):5914-20. PubMed ID: 9550388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
    Frauwirth K; Shastri N
    Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
    Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
    Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of bovine invariant chain (Ii) gene by nucleotide sequencing.
    Niimi M; Nakai Y; Aida Y
    Biochem Biophys Res Commun; 1996 May; 222(1):7-12. PubMed ID: 8630076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structure for the trimeric MHC class II-associated invariant chain transmembrane domain.
    Kukol A; Torres J; Arkin IT
    J Mol Biol; 2002 Jul; 320(5):1109-17. PubMed ID: 12126629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
    Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
    Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
    J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
    Germain RN
    Semin Immunol; 1995 Dec; 7(6):361-72. PubMed ID: 8775462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The invariant chain gene intronic enhancer shows homology to class II promoter elements.
    Moore BB; Cao ZA; McRae TL; Woo CH; Conley S; Jones PP
    J Immunol; 1998 Aug; 161(4):1844-52. PubMed ID: 9712052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.